Tags

Type your tag names separated by a space and hit enter

Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5.
Ther Apher Dial. 2009 Jun; 13(3):199-204.TA

Abstract

It is still controversial whether the mode of dialysis or preexisting comorbidities may influence the prognosis of patients with chronic kidney disease stage 5. Therefore, we performed a prospective case control study to evaluate whether the mode of dialysis may influence outcome. We found 25 cases on peritoneal dialysis (PD) treatment and 75 age and sex-matched controls on hemodialysis (HD) treatment for more than 3 months. Analysis was by intention-to-treat. During the follow up of 58 months, 6 out of 25 patients (24%) died in the PD group, whereas in the HD group 26 out of 75 patients (35%) died (relative risk 0.69 [95% CI 0.32 to 1.49]; P = 0.46). Survival was not significantly different between the groups as indicated by Mantel-Cox log-rank test (hazard ratio 0.52 [95% CI 0.25 to 1.10]; P = 0.11). Multiple variable regression showed that age and diabetes mellitus, but not mode of dialysis, predicted death in patients with chronic kidney disease. It is concluded that age and comorbidities but not mode of dialysis are important to predict survival in patients with chronic kidney disease stage 5.

Authors+Show Affiliations

Department of Nephrology, Charité University Medical School, Hindenburgdamm 30, Berlin, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19527466

Citation

Maier, Alexandra, et al. "Hemodialysis Versus Peritoneal Dialysis: a Case Control Study of Survival in Patients With Chronic Kidney Disease Stage 5." Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, vol. 13, no. 3, 2009, pp. 199-204.
Maier A, Stocks F, Pommer W, et al. Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5. Ther Apher Dial. 2009;13(3):199-204.
Maier, A., Stocks, F., Pommer, W., Zidek, W., Tepel, M., & Scholze, A. (2009). Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5. Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 13(3), 199-204. https://doi.org/10.1111/j.1744-9987.2009.00660.x
Maier A, et al. Hemodialysis Versus Peritoneal Dialysis: a Case Control Study of Survival in Patients With Chronic Kidney Disease Stage 5. Ther Apher Dial. 2009;13(3):199-204. PubMed PMID: 19527466.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5. AU - Maier,Alexandra, AU - Stocks,Franziska, AU - Pommer,Wolfgang, AU - Zidek,Walter, AU - Tepel,Martin, AU - Scholze,Alexandra, PY - 2009/6/17/entrez PY - 2009/6/17/pubmed PY - 2009/9/1/medline SP - 199 EP - 204 JF - Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy JO - Ther Apher Dial VL - 13 IS - 3 N2 - It is still controversial whether the mode of dialysis or preexisting comorbidities may influence the prognosis of patients with chronic kidney disease stage 5. Therefore, we performed a prospective case control study to evaluate whether the mode of dialysis may influence outcome. We found 25 cases on peritoneal dialysis (PD) treatment and 75 age and sex-matched controls on hemodialysis (HD) treatment for more than 3 months. Analysis was by intention-to-treat. During the follow up of 58 months, 6 out of 25 patients (24%) died in the PD group, whereas in the HD group 26 out of 75 patients (35%) died (relative risk 0.69 [95% CI 0.32 to 1.49]; P = 0.46). Survival was not significantly different between the groups as indicated by Mantel-Cox log-rank test (hazard ratio 0.52 [95% CI 0.25 to 1.10]; P = 0.11). Multiple variable regression showed that age and diabetes mellitus, but not mode of dialysis, predicted death in patients with chronic kidney disease. It is concluded that age and comorbidities but not mode of dialysis are important to predict survival in patients with chronic kidney disease stage 5. SN - 1744-9987 UR - https://www.unboundmedicine.com/medline/citation/19527466/Hemodialysis_versus_peritoneal_dialysis:_a_case_control_study_of_survival_in_patients_with_chronic_kidney_disease_stage_5_ L2 - https://doi.org/10.1111/j.1744-9987.2009.00660.x DB - PRIME DP - Unbound Medicine ER -